JJBenzo, many thanks for your investment thesis. You've clearly put a great deal of time and effort into understanding the potential that Arrayit may realize.
Just out of curiosity... have you probed the folks at Arrayit about any prior experience in providing FDA submissions.
More than ever I'm seeing today's FDA as a model of our Government inaction.
Scanned it and will dig into deeper soon. A few questions though. What would be the price range of an Ovarian test and is your $15 profit based on any information coming from the company. What is the best data point out there that would allow for a reasonable expectation of adoption as a routine test. You run numbers on 50%. Is that really high or possibly even conservative.
Then is there a short version of IP issues to their technology and/or any others that have comparable technology under development.
FYI, use to trade and invest at times in SQNM quite a bit.
Then what's the deal on your JH comment and his leaving. really sourced, speculation or just wishful thinking. I'd say his departure would be a positive no matter what.
Market Data 
Markets 
AI
